An R&D Focus

With years upon years of first-hand experience in advancing the development of the modern medicine and drugs, we know how to make the world healthier!

ReHealth’s development programs in Gastroenterology are focused on advancing new treatments in constipation and diabetic gastroparesis. Key programs include low-dose and colonic release formulations for Linzess and relamorelin, a novel treatment for Diabetic Gastroparesis, a debilitating condition that has not had a new therapeutic option in more than 30 years.

Here's how it works:

ReHealth’s development efforts in anti-infectives are focused on bringing forward treatments for difficult to treat infections.
Lead programs include Ceftazidime/Avibactam, a potential treatment for hospital acquired bacteria pneumonia/ventilator acquired bacterial pneumonia.
Also we focus on Aztreonam/Avibactam, a novel treatment for gram-negative infections. ReHealth is also focused on adding new innovative programs throughout its seven therapeutic areas.

Apply for a Job with Us!

Each year we've got a lot of miscellaneous job offerings. See which ones are right for you!

Customers, who've done such transfers:

I have been taking 100 mg bid for over a year now. I have never been so normal feeling in my gut. I do have some bad days with it, just depends on what I…

Dr. Steven Moffat

Today was my first day on Revitrox. I was prescribed two 100 mg pills a day. So far it has been okay. I decided to be risky and really test it and have an iced…

Dr. Mary Winker

I have had IBSD for 37 years which has made it impossible to hold down a job for long periods of time. I get a job and work as long as possible when they get…

Dr. John Wallace